CJC NO DAC 10mg

Performance Profile

• Pulsatile GH Release Research: Triggers a quick, short-acting GH pulse from the pituitary in GHRH receptor research models — mimicking the body’s natural episodic GH release pattern.
• Short-Acting GHRH Analogue: Clears the system rapidly after activation — useful for studying episodic GH stimulation without the prolonged receptor occupation of the DAC version.
• Protocol Flexibility: Short half-life makes it well-suited for timed, controlled GH pulse research protocols where precise release windows are important.

Quick Summary

• Best For: Episodic GH pulse research, GHRH receptor studies, timed secretagogue protocols.
• Use Case: Studying pulsatile GH release patterns without sustained receptor activity — useful for research that needs to mirror natural GH rhythm.
• Commonly Studied With: Ipamorelin — GHRH + GHRP combination research is one of the most established GH axis protocols.

For research purposes only. Not for human consumption. For use by licensed researchers only. These compounds have not been evaluated or approved by Health Canada for human use.